Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$12.7M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
1 of 7 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 16 business days late.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured
The 43 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| Aug 12 | LGND | Ligand Pharmaceuticals INC | MEXER◷◆ | 16,179 | — | — | — | Open the original filing on SEC.gov |
| Aug 12 | LGND | Ligand Pharmaceuticals INC | MEXER◷◆ | 7,171 | — | — | — | Open the original filing on SEC.gov |
| Aug 12 | LGND | Ligand Pharmaceuticals INC | MEXER◷◆ | 2,869 | — | — | — | Open the original filing on SEC.gov |
| Aug 12 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 31,641 | $292.07 | $9.2M | -53.3% | Open the original filing on SEC.gov |
| Aug 12 | LGND | Ligand Pharmaceuticals INC | MEXER◷ | 3,348 | $68.74 | $230.1K | +6.0% | Open the original filing on SEC.gov |
| Aug 12 | LGND | Ligand Pharmaceuticals INC | MEXER◷ | 7,171 | $57.22 | $410.3K | +14.7% | Open the original filing on SEC.gov |
| Aug 12 | LGND | Ligand Pharmaceuticals INC | MEXER◷ | 2,869 | $55.75 | $159.9K | +6.2% | Open the original filing on SEC.gov |
| Aug 12 | LGND | Ligand Pharmaceuticals INC | MEXER◷ | 2,074 | $70.04 | $145.3K | +4.7% | Open the original filing on SEC.gov |
| Aug 12 | LGND | Ligand Pharmaceuticals INC | MEXER◷ | 16,179 | $52.84 | $854.9K | +58.4% | Open the original filing on SEC.gov |
| Jun 30 | LGND | Ligand Pharmaceuticals INC | JOTHER | 17 | $160.71 | $2.7K | +<0.1% | Open the original filing on SEC.gov |
| May 27 | LGND | Ligand Pharmaceuticals INC | MEXER◆ | 764 | — | — | — | Open the original filing on SEC.gov |
| May 27 | LGND | Ligand Pharmaceuticals INC | MEXER◆ | 972 | — | — | — | Open the original filing on SEC.gov |
| May 27 | LGND | Ligand Pharmaceuticals INC | MEXER | 972 | $52.84 | $51.4K | +3.6% | Open the original filing on SEC.gov |
| May 27 | LGND | Ligand Pharmaceuticals INC | MEXER | 764 | $63.62 | $48.6K | +2.9% | Open the original filing on SEC.gov |
| Mar 11 | LGND | Ligand Pharmaceuticals INC | MEXER◷◆ | 2,405 | — | — | — | Open the original filing on SEC.gov |
| Mar 11 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 3,057 | $225.00 | $687.8K | -12.7% | Open the original filing on SEC.gov |
| Mar 11 | LGND | Ligand Pharmaceuticals INC | MEXER◷ | 2,405 | $92.65 | $222.8K | +11.1% | Open the original filing on SEC.gov |
| Mar 4 | LGND | Ligand Pharmaceuticals INC | MEXER◷◆ | 466 | — | — | — | Open the original filing on SEC.gov |
| Mar 4 | LGND | Ligand Pharmaceuticals INC | MEXER◷◆ | 1,607 | — | — | — | Open the original filing on SEC.gov |
| Mar 4 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 3,413 | $208.80 | $712.6K | -13.6% | Open the original filing on SEC.gov |
| Mar 4 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 2,457 | $207.91 | $510.8K | -8.9% | Open the original filing on SEC.gov |
| Mar 4 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 1,588 | $206.89 | $328.5K | -5.5% | Open the original filing on SEC.gov |
| Mar 4 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 1,457 | $205.79 | $299.8K | -4.8% | Open the original filing on SEC.gov |
| Mar 4 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 743 | $204.74 | $152.1K | -2.4% | Open the original filing on SEC.gov |
| Mar 4 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 668 | $203.63 | $136K | -2.1% | Open the original filing on SEC.gov |
| Mar 4 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 697 | $202.79 | $141.3K | -2.1% | Open the original filing on SEC.gov |
| Mar 4 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 950 | $201.73 | $191.6K | -2.8% | Open the original filing on SEC.gov |
| Mar 4 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 698 | $201.09 | $140.4K | -2.0% | Open the original filing on SEC.gov |
| Mar 4 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 53 | $200.08 | $10.6K | -0.1% | Open the original filing on SEC.gov |
| Mar 4 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 699 | $198.71 | $138.9K | -2.0% | Open the original filing on SEC.gov |
| Mar 4 | LGND | Ligand Pharmaceuticals INC | MEXER◷ | 466 | $80.72 | $37.6K | +1.4% | Open the original filing on SEC.gov |
| Mar 4 | LGND | Ligand Pharmaceuticals INC | MEXER◷ | 1,607 | $58.49 | $94K | +4.9% | Open the original filing on SEC.gov |
| Mar 2 | LGND | Ligand Pharmaceuticals INC | AGRANT◆ | 23,527 | — | — | — | Open the original filing on SEC.gov |
| Mar 2 | LGND | Ligand Pharmaceuticals INC | AGRANT | 4,933 | — | — | +14.9% | Open the original filing on SEC.gov |
| Feb 15 | LGND | Ligand Pharmaceuticals INC | FTAX | 1,270 | $183.83 | $233.5K | -3.7% | Open the original filing on SEC.gov |
| Feb 15 | LGND | Ligand Pharmaceuticals INC | FTAX | 1,223 | $183.83 | $224.8K | -3.4% | Open the original filing on SEC.gov |
| Feb 15 | LGND | Ligand Pharmaceuticals INC | FTAX | 1,026 | $183.83 | $188.6K | -2.8% | Open the original filing on SEC.gov |
| Feb 14 | LGND | Ligand Pharmaceuticals INC | FTAX | 4,483 | $183.83 | $824.1K | -10.9% | Open the original filing on SEC.gov |
| Feb 14 | LGND | Ligand Pharmaceuticals INC | AGRANT | 8,810 | — | — | +27.4% | Open the original filing on SEC.gov |
| Feb 14 | LGND | Ligand Pharmaceuticals INC | FTAX | 3,761 | $183.83 | $691.4K | -10.5% | Open the original filing on SEC.gov |
| Feb 14 | LGND | Ligand Pharmaceuticals INC | AGRANT | 7,390 | — | — | +25.9% | Open the original filing on SEC.gov |